bf/NASDAQ:OCUL_icon.jpeg

COM:OCUTX

Ocular Therapeutix

  • Stock

USD

Last Close

8.52

22/11 21:00

Market Cap

1.11B

Beta: -

Volume Today

819.88K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
66.50K
-
133.50K
100.75%
123.50K
7.49%
117.50K
4.86%
169.50K
44.26%
585.50K
245.43%
1.08M
84.03%
1.23M
13.74%
1.61M
31.54%
2.14M
32.72%
average payables
930.50K
-
1.64M
75.87%
2.04M
24.44%
2.84M
39.63%
3.27M
14.93%
3.12M
4.64%
2.99M
4.11%
3.65M
22.15%
4.86M
33.06%
4.76M
2.09%
average receivables
299K
-
261K
12.71%
221.50K
15.13%
238K
7.45%
213.50K
10.29%
1.37M
543.79%
7.40M
438.38%
16.69M
125.59%
21.23M
27.18%
23.75M
11.88%
book value per share
5.51
-
3.85
30.05%
2.10
45.63%
0.91
56.71%
0.94
3.74%
-0.08
108.52%
1.25
1,662.17%
1.15
8.03%
0.46
60.05%
0.00
99.77%
capex per share
-0.12
-
-0.08
35.33%
-0.08
1.09%
-0.29
270.30%
-0.05
82.69%
-0.05
0.26%
-0.01
72.00%
-0.02
12.91%
-0.05
209.19%
-0.00
99.85%
capex to depreciation
-2.30
-
-2.36
2.37%
-2.18
7.63%
-5.08
133.13%
-0.83
83.73%
-0.88
7.05%
-0.30
65.71%
-0.49
62.62%
-1.76
257.17%
-2.04
15.84%
capex to operating cash flow
0.06
-
0.05
14.29%
0.06
7.11%
0.16
189.68%
0.04
76.53%
0.03
24.82%
0.02
45.56%
0.02
15.99%
0.06
242.18%
0.09
39.05%
capex to revenue
-1.63
-
-1.02
37.75%
-1.02
0.09%
-4.29
321.97%
-0.95
77.88%
-0.53
44.22%
-0.05
90.87%
-0.03
43.23%
-0.07
162.97%
-0.11
45.80%
cash per share
7.02
-
4.52
35.65%
2.75
39.25%
1.44
47.51%
1.42
1.60%
1.20
15.23%
3.75
212.20%
2.15
42.75%
1.33
38.08%
0.00
99.83%
days of inventory on hand
533.46
-
153.32
71.26%
93.10
39.28%
97.44
4.66%
170.33
74.81%
149.77
12.07%
210.45
40.52%
103.55
50.79%
158.70
53.26%
159.31
0.38%
days payables outstanding
5.28K
-
2.24K
57.58%
1.74K
22.14%
2.85K
63.59%
2.33K
18.40%
513.04
77.96%
474.69
7.47%
380.41
19.86%
411.87
8.27%
303.35
26.35%
days sales outstanding
155.55
-
40.25
74.12%
48.36
20.13%
42.90
11.29%
36.87
14.06%
220.02
496.79%
256.97
16.79%
177.25
31.02%
151.16
14.72%
165.12
9.24%
debt to assets
0.19
-
0.14
27.17%
0.21
50.77%
0.33
55.70%
0.34
4.41%
0.75
122.08%
0.22
70.39%
0.29
29.00%
0.43
49.57%
0.33
23.17%
debt to equity
0.25
-
0.17
32.69%
0.30
76.44%
0.69
129.08%
0.69
0.28%
-16.35
2,465.99%
0.77
104.70%
0.67
12.72%
1.82
171.08%
0.92
49.64%
dividend yield
0.06
-
0.01
83.77%
0.03
-
0.00
94.27%
0.00
-
0.00
124.48%
earnings yield
-0.11
-
-0.18
59.61%
-0.22
17.93%
-0.49
129.66%
-0.38
23.06%
-0.50
32.24%
-0.13
74.76%
-0.02
84.01%
-0.29
1,346.94%
-0.00
99.93%
enterprise value
228.03M
-
202.29M
11.29%
190.42M
5.87%
104.72M
45.01%
122.42M
16.91%
183.74M
50.08%
1.09B
492.13%
427.28M
60.73%
178.00M
58.34%
381.65B
214,306.98%
enterprise value over ebitda
-8.28
-
-5.32
35.77%
-4.43
16.80%
-1.70
61.52%
-2.10
23.44%
-2.17
3.34%
-17.36
699.04%
-5.48
68.44%
-2.29
58.26%
-4.63K
202,530.24%
ev to operating cash flow
-11.13
-
-5.99
46.12%
-5.60
6.58%
-2.07
62.95%
-2.49
19.87%
-2.37
4.77%
-20.32
757.76%
-6.52
67.91%
-2.99
54.18%
-5.43K
181,853.18%
ev to sales
295.37
-
115.59
60.87%
100.91
12.70%
54.46
46.04%
61.52
12.97%
43.47
29.34%
62.52
43.82%
9.82
84.30%
3.46
64.79%
6.59K
190,684.05%
free cash flow per share
-2.04
-
-1.53
25.17%
-1.45
5.28%
-2.04
40.79%
-1.34
34.19%
-1.76
31.46%
-0.90
49.21%
-0.87
2.42%
-0.82
5.73%
-0.00
99.89%
free cash flow yield
-0.09
-
-0.16
87.83%
-0.17
6.03%
-0.46
164.80%
-0.34
26.42%
-0.45
32.46%
-0.04
90.31%
-0.13
189.80%
-0.29
133.83%
-0.00
99.93%
graham net net
5.22
-
3.64
30.36%
1.83
49.65%
0.43
76.35%
0.45
3.88%
-0.56
225.38%
0.86
251.93%
0.83
2.65%
0.07
91.63%
0.00
99.07%
graham number
18.26
-
12.18
33.31%
9.22
24.32%
6.70
27.29%
5.66
15.51%
1.89
66.56%
8.61
354.57%
1.91
77.75%
2.92
52.66%
0.00
99.84%
income quality
0.72
-
0.85
18.66%
0.76
10.40%
0.80
4.69%
0.82
3.07%
0.90
9.43%
0.34
61.69%
10.00
2,807.04%
0.84
91.61%
0.87
3.68%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
interest coverage
-24.21
-
-22.16
8.49%
-25.79
16.40%
-32.73
26.91%
-34.00
3.87%
-14.06
58.63%
-9.29
33.97%
-11.70
25.98%
-11.20
4.25%
7.27
164.87%
interest debt per share
1.50
-
0.73
51.27%
0.70
4.53%
0.69
1.04%
0.70
0.75%
1.45
107.70%
1.07
25.75%
0.86
19.93%
0.93
7.93%
0.00
99.91%
inventory turnover
0.68
-
2.38
247.93%
3.92
64.68%
3.75
4.45%
2.14
42.79%
2.44
13.73%
1.73
28.83%
3.52
103.23%
2.30
34.75%
2.29
0.38%
invested capital
0.25
-
0.17
32.69%
0.30
76.44%
0.69
129.08%
0.69
0.28%
-16.35
2,465.99%
0.77
104.70%
0.67
12.72%
1.82
171.08%
0.92
49.64%
market cap
250.56M
-
217.80M
13.07%
207.71M
4.63%
128.24M
38.26%
151.70M
18.29%
178.83M
17.88%
1.26B
603.22%
532.46M
57.66%
216.02M
59.43%
381.76B
176,625.69%
net current asset value
56.69M
-
86.27M
52.18%
46.97M
45.55%
14.05M
70.07%
19.02M
35.36%
-22.20M
216.69%
60.39M
372.04%
74.41M
23.21%
15.72M
78.88%
71.31M
353.69%
net debt to ebitda
0.82
-
0.41
50.15%
0.40
1.47%
0.38
4.84%
0.50
31.41%
-0.06
111.54%
2.71
4,765.47%
1.35
50.17%
0.49
63.79%
1.36
179.46%
net income per share
-2.69
-
-1.71
36.41%
-1.80
5.34%
-2.20
22.10%
-1.51
31.18%
-1.99
31.24%
-2.63
32.27%
-0.14
94.62%
-0.83
483.34%
-0.00
99.89%
operating cash flow per share
-1.92
-
-1.45
24.55%
-1.37
5.62%
-1.75
27.83%
-1.29
26.26%
-1.71
32.68%
-0.88
48.56%
-0.86
2.66%
-0.78
9.64%
-0.00
99.89%
payables turnover
0.07
-
0.16
135.73%
0.21
28.44%
0.13
38.87%
0.16
22.55%
0.71
353.64%
0.77
8.08%
0.96
24.78%
0.89
7.64%
1.20
35.77%
receivables turnover
2.35
-
9.07
286.42%
7.55
16.76%
8.51
12.73%
9.90
16.36%
1.66
83.24%
1.42
14.38%
2.06
44.97%
2.41
17.26%
2.21
8.46%
research and ddevelopement to revenue
24.46
-
15.21
37.82%
14.34
5.68%
16.06
11.96%
18.55
15.52%
9.72
47.60%
1.65
83.04%
1.15
30.21%
1.04
9.78%
1.06
1.62%
return on tangible assets
-0.37
-
-0.36
1.65%
-0.60
65.54%
-1.14
91.70%
-0.79
30.93%
-1.14
44.61%
-0.61
46.63%
-0.05
91.35%
-0.42
705.64%
-0.32
24.60%
revenue per share
0.07
-
0.08
3.89%
0.08
1.00%
0.07
12.24%
0.05
21.76%
0.09
78.83%
0.29
206.81%
0.57
98.88%
0.67
17.58%
0.00
99.90%
roe
-0.49
-
-0.44
9.10%
-0.86
93.73%
-2.42
182.04%
-1.61
33.66%
24.78
1,640.63%
-2.10
108.47%
-0.12
94.15%
-1.79
1,360.12%
-0.89
50.58%
roic
-0.37
-
-0.37
0.87%
-0.65
74.66%
-1.41
116.02%
-0.94
33.43%
-1.36
44.97%
-0.45
66.93%
-0.83
85.27%
-0.64
23.28%
-0.45
29.51%
sales general and administrative to revenue
8.95
-
5.24
41.51%
5.83
11.35%
8.07
38.30%
9.44
17.05%
5.23
44.56%
1.31
74.90%
0.73
44.23%
0.63
14.57%
0.59
6.28%
shareholders equity per share
5.51
-
3.85
30.05%
2.10
45.63%
0.91
56.71%
0.94
3.74%
-0.08
108.52%
1.25
1,662.17%
1.15
8.03%
0.46
60.05%
0.00
99.77%
stock based compensation to revenue
3.42
-
2.65
22.58%
3.16
19.04%
3.81
20.62%
3.76
1.23%
2.07
44.89%
0.43
79.12%
0.34
20.48%
0.33
4.27%
0.31
6.50%
tangible asset value
58.70M
-
89.59M
52.63%
52.01M
41.95%
26.15M
49.73%
35.88M
37.21%
-3.63M
110.12%
76.09M
2,196.28%
88.00M
15.64%
35.38M
59.80%
91.13M
157.59%
tangible book value per share
5.51
-
3.85
30.05%
2.10
45.63%
0.91
56.71%
0.94
3.74%
-0.08
108.52%
1.25
1,662.17%
1.15
8.03%
0.46
60.05%
0.00
99.77%
working capital
70.31M
-
101.61M
44.51%
61.60M
39.38%
29.91M
51.44%
47.03M
57.24%
48.14M
2.35%
219.50M
355.94%
164.96M
24.84%
98.23M
40.45%
197.34M
100.89%

All numbers in USD (except ratios and percentages)